SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

24 Jun 2015 15:56

RNS Number : 1380R
Rentokil Initial PLC
24 June 2015
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

 

Rentokil Initial plc

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

 

Pursuant to (i) and (iii) above

 

3. Name of person discharging managerial responsibilities/director

 

Martin Sawkins - PDMR

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

Not applicable

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

Pursuant to 3.above

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

Ordinary shares of 1 pence each

 

7. Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

 

Martin Sawkins

 

8 State the nature of the transaction

 

Exercise of Performance share plan vested award 2012 - Final vested award 8 May 2015 - 103,254 and sale of shares to meet tax liabilities.

 

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

103,254 Performance shares plan award 2012 - awarded after application of performance conditions

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.00566%

 

11. Number of shares, debentures or financial instruments relating to shares disposed

.

48,701 sold to meet tax liabilities and dealing costs. Balance shares held 54,553

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

 

0.00267%

 

13. Price per share or value of transaction

 

150.5p

 

14. Date and place of transaction

 

19 June 2015, London

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

84,757 Ordinary shares - 0.00465%

 

16. Date issuer informed of transaction

 

22 June 2015

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17. Date of grant

 

N/A

 

18. Period during which or date on which it can be exercised

 

N/A

 

19. Total amount paid (if any) for grant of the option

 

N/A

 

20. Description of shares or debentures involved (class and number)

 

N/A

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

N/A

 

22. Total number of shares or debentures over which options held following notification

 

N/A

 

23. Any additional information

 

Sale of 48,701 ordinary shares to satisfy tax liability and dealing costs

24. Name of contact and telephone number for queries

 

Alexandra Laan, Assistant Company Secretary - +44(0)1276 607444

 

25. Name of authorised official of issuer responsible for making notification and date of notification

 

Daragh Fagan - General Counsel & Company Secretary - 24 June 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDLXUDBGUS
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.